REZUROCK is undoubtedly an inhibitor of UGT1A1. Coadministration of REZUROCK with a UGT1A1 substrate reduced plasma concentrations from the glucuronide metabolite, which can boost the hazard of adverse reactions connected with delicate substrates of UGT1A1Thailand's stem cell clinics are not merely treatment facilities but in addition hubs of study